Choose speciality channel:   Choose sector channel:     Search the site

Press Release


Porter Novelli launch Ultrashape

Porter Novelli launch Ultrashape

Porter Novelli has been appointed by UltraShape to promote a revolutionary ultrasound system for non-invasive body contouring in the UK.

Porter Novelli is also working with UltraShape’s international headquarters in Israel, spearheading the development and coordination of the company’s global public relations strategy being implemented in France, Italy, Israel and the US.

To reflect the system’s key differentiators Porter Novelli captured the essence of the product, developing a brand name for the incorporated technology G-NIUS Technology (Guided, Non-Invasive Focused Ultrasound Selective Technology).

UltraShape UK is a wholly owned subsidiary of Israeli company UltraShape Limited. Established in 2000, it has since grown rapidly as a company.

Its body contouring system is the first and only non-invasive solution of its type to effectively break down fat cells, and has been fully approved by the European Commission. It is already used in 35 countries, with 150 systems installed and over 14,000 commercial treatments already administered.

Commenting on the appointment, Lucy Melling, Porter Novelli’s Consumer Director said: “We are delighted to be working alongside UltraShape in launching this groundbreaking new product, both in the UK and globally.

Our focus is to drive demand by communicating the safety, ease and effectiveness of the treatment to consumers, combined with the potential for revenue generation on offer to medical professionals administering the treatment. UltraShape’s sales abroad are booming and we look forward to driving that success in the UK.”

Lee Brine, Manager, UltraShape UK said Porter Novelli’s impressive credentials and understanding of our business made them the obvious partner choice to launch our product.

“We see a promising future for UltraShape, and are looking forward to benefiting from the strategic direction and consumer expertise Porter Novelli bring as we enter the UK marketplace.”


Thomas Fern
Porter Novelli
+44 (0)20 7853 2231   direct line

can i take antabuse and naltrexone can i take antabuse and naltrexone can i take antabuse and naltrexone
coupons for cialis printable open drug coupon card
discount prescriptions coupons link printable coupons for cialis
prescription coupon card open prescription savings card
cialis coupon discount coupons for cialis
forest laboratories patient assistance read forest patient assistance
is there a generic for bystolic bystolic coupon
sumatriptan 100 mg sumatriptan 100 mg sumatriptan 100 mg
bystolic manufacturer coupon does bystolic have a generic bystolic coupon 2014
aida kreuzfahrt aidasol aida angebote
naproxennatrium naproxen en ibuprofen naproxen nsaid
kamagra 100 kamagra jelly
depakin bustine read depakin 300
pro-choice abortion facts read pill for abortion
amoxicillin-rnp amoxicillin-rnp amoxicillin dermani haqqinda
the cost of abortion abortions facts how do abortion pill work
price of abortion pill what is abortion pill buy abortion pill
free cialis coupons free coupon for cialis cialis coupons from lilly
printable coupons for cialis cialis coupons 2015
viagra recenze viagra wiki viagra prodej
nootropil 800 g nootropil 1200 nootropil
cialis coupons printable prescription coupon card cialis manufacturer coupon 2016
flagyl jarabe flagyl plm flagyl vademecum
buy abortion pill abortion pill pictures reasons for abortion pill
abortion pill process abortion pill complications articles on abortion pill
half life naltrexone click naltrexone dosage forms

Check out 12ahead, our brand new platform covering the latest in cutting-edge digital marketing and creative technology from around the globe.

12ahead identifies emerging trends and helps you to understand how they can apply to modern-day companies.

We believe 12ahead can put you and your business 12 months ahead of the competition. Sign up for a free trial today.